Table 1

Summary of evaluation methods

Type of economic evaluationCosts/outcomesJustification for inclusionSourcesCost-effectiveness measure
Cost-consequence analysis comparing three phases (preannouncement vs preparatory vs post implementation)Costs (healthcare and personal spend on nicotine products)No cost-effectiveness measure presented—balance sheet format presenting disaggregated costs and outcomes
GP/nurse visits (PiC and staff)Potential for change with reduced exposure to tobacco/SHS (eg, for coughs and colds)TIPs surveys of PiC and staff (all three phases)
Outpatient visits (PiC only)Potential for change with reduced exposure to tobacco/SHS for smoking-related diseasesNHS NSS (ISD SMR00) (June 2016 to November 2019)
Inpatient stays (PiC only)Potential for change with reduced exposure to tobacco/SHS for smoking-related diseases (eg, stays for cardiovascular events and respiratory disease)NHS NSS (ISD SMR01) (June 2016 to November 2019)
Mental health stays (PiC only)Potential for change with no licit access to tobacco, which could impact levels of distressNHS NSS (ISD SMR04) (June 2016 to November 2019)
Accident and emergency (PiC only)Potential for change with reduced exposure to tobacco/SHS for smoking-related diseases (eg, acute health events) and with no licit access to tobacco (eg, violence, including self-harm)NHS NSS (ISD Unscheduled Care A&E2) (June 2016 to November 2019)
Ambulance (PiC only)Potential for change with reduced exposure to tobacco/SHS for smoking-related diseases (eg, acute health events) and with no licit access to tobacco (eg, violence, including self-harm)Scottish Prison Service (June 2016 to November 2019)
Medication—nicotine dependence and smoking-related illness (PiC only)Potential for change with reduced exposure to tobacco/SHS (need for medication for smoking-related diseases), and with no licit access to tobacco (need for nicotine dependence products)National Procurement, NHS NSS (June 2016 to November 2019)
Tobacco products (PiC and staff)PiC—expected decrease when unavailable in canteen after implementation; staff—potential change in spend if influenced by policyPiC—SPS canteen purchase data (3 months prior to implementation); staff—TIPs staff survey all three phases
E-cigarettes (PiC only)Expected increased use with no licit access to tobacco in later phasesSPS canteen purchase data (3 months prior to implementation and 1 year after)
Outcomes (health and non-health related)
Concentration of secondhand smoke (PM2.5)Expected reduction due to policy implementationTIPs study measurements (in all three phases)
Health-related quality of life—health utilities (PiC and staff)Potential for change for PiC and staff due to reduced exposure to SHS and no licit access to tobaccoTIPs surveys for PiC and staff included a Euro-Qol-5D (EQ-5D) questionnaire (in all three phases)
Prisoner-on-staff assaultsPotential for change with no licit access to tobacco later in preparatory and post implementation phasesScottish Prison Service (November 2017 to November 2019)
Prisoner-on-prisoner assaultsPotential for change with no licit access to tobacco later in preparatory and post implementation phasesScottish Prison Service (November 2017 to November 2019)
All-cause mortality (deaths in custody—PiC)Potential for change with reduced exposure to tobacco/SHS for smoking-related diseasesScottish Prison Service (June 2016 to November 2019)
FiresPotential for change due to no lighters permitted after implementation and frustration at no licit access to tobaccoScottish Prison Service (June 2016 to November 2019)
Management of an Offender at Risk due to any Substance (MORS) policyPotential for change with no licit access to tobacco and with the introduction of e-cigarettes in prisonsScottish Prison Service (June 2016 to November 2019)
Cost-effectiveness analysis comparing absence and presence of smoke-free policy (preannouncement to post implementation phases)Costs—total of all costs included in cost-consequence analysisPotential for change due to absence of licit tobacco—details aboveVarious sources—details aboveIncremental cost per 10 µg/m3 reduction in PM2.5
Outcome—concentration of secondhand smoke (PM2.5)Expected reduction due to policy implementationTIPs study measurements (in all three phases)
Cost-utility analysis comparing absence and presence of smoke-free policy (preannouncement to post implementation phases)Costs—total of all costs included in cost-consequence analysisPotential for change due to absence of licit tobacco—details aboveIncremental cost per quality-adjusted life-year
Outcome—quality-adjusted life-years (PiC and staff)Potential for change for PiC and staff due to reduced exposure to SHS and no licit access to tobaccoTIPs surveys for PiC and staff included an EQ-5D questionnaire (in all three phases) combined with 12-month time period
  • A&E, accident and emergency; GP, general practitioner; ISD SMR, Information Services Division Scottish Morbidity Records; NHS NSS, National Health Service National Services Scotland; PiC, people in custody; PM, particulate matter; SHS, secondhand smoke; SPS, Scottish Prison Service; TIPs, Tobacco in Prisons.